Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) Antikörper:
anti-Mouse (Murine) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal AGLU Primary Antibody für WB - ABIN920552
Hilkens, Tager, Buijs, Brouwer-Kelder, Van Thienen, Tegelaers, Hilgers: Monoclonal antibodies against human acid alpha-glucosidase. in Biochimica et biophysica acta 1982
MGAM, or nearby regulatory elements, may be involved in the etiology of oral clefts.
Starch internal structure modulates its susceptibility to MGAM. The internal branch amounts negatively affect the glucose release rate.
The over-expression of MGAM was confirmed with a 6.6 fold increase in expression at the mRNA level whereas the fold change in ADAM9 (zeige ADAM9 Antikörper) demonstrated a 1.6 fold increase.
Findings suggest that C-terminal subunits of recombinant maltase-glucoamylase (MGAM) assists alpha-amylase (zeige AMY Antikörper) in digesting starch molecules and potentially may compensate for developmental or pathological amylase (zeige AMY Antikörper) deficiencies.
These results suggest that the N-terminal and C-terminal catalytic domains of maltase-glucoamylase differ in their substrate specificities and inhibitor tolerance despite their structural relationship
we report crystal structures of C-terminal maltase-glucoamylase alone at a resolution of 3.1 angstroms, and in complex with its inhibitor acarbose
analysis of substrate selectivity of human maltase-glucoamylase and sucrase-isomaltase N-terminal domains
genetic analysis of MGAM, exon boundaries, and chromosome mapping
Raw starch granule degradation with recombinanat human MGAM indicates that pancreatic alpha-amylase (zeige AMY2A Antikörper) hydrolysis is not a requirement for native starch digestion in the human small intestine.
Intestinal maltase-glycoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity.
investigation of dietary control of Mgam expression in jejunum: high starch diet induces Mgam through mechanism involving increased acetylation of histones and increased binding of CREBBP (zeige CREBBP Antikörper), CDX2 (zeige CDX2 Antikörper), and HNF1 (zeige HNF1A Antikörper) to Mgam gene
The alpha-glucogenic activities of the jejunal mucosa with and without added recombinant pancreatic alpha-amylase (zeige AMY2A Antikörper), using a range of food starch substrates are reported.
mucosal alpha-glucogenic activity of Mgam plays a crucial role in the regulation of prandial glucose homeostasis
This gene encodes maltase-glucoamylase, which is a brush border membrane enzyme that plays a role in the final steps of digestion of starch. The protein has two catalytic sites identical to those of sucrase-isomaltase, but the proteins are only 59% homologous. Both are members of glycosyl hydrolase family 31, which has a variety of substrate specificities.
, brush border hydrolase
, maltase-glucoamylase, intestinal
, acid (Pompe disease, glycogen storage disease type II)
, acid alpha-glucosidase
, acid maltase
, glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II)
, lysosomal alpha-glucosidase
, sucrase-isomaltase, intestinal